Search research articles
Contact Us
Filters
Showing results (11-20 of 31) with videos related to
Page
of 4
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 8, 2017
Next-Generation Sequencing in Adult B Cell Acute Lymphoblastic Leukemia Patients
Olga Sala Torra, Megan Othus, David W Williamson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 28, 2014
Detection of minimal residual disease in B lymphoblastic leukemia by high-throughput sequencing of IGH
David Wu, Ryan O Emerson, Anna Sherwood, et al.
Science Translational Medicine
|
August 21, 2015
High-throughput pairing of T cell receptor α and β sequences
Bryan Howie, Anna M Sherwood, Ashley D Berkebile, et al.
American Journal of Hematology
|
May 4, 2026
Post CAR-T Measurable Residual Disease Monitoring in Mantle Cell Lymphoma Enables Early Detection of Disease Relapse
Snegha Ananth, Neha Agarwal, Bita Sahaf, et al.
Journal of Clinical Pathology
|
December 15, 2022
Characterisation of T cell receptor repertoires in coeliac disease
Lik Wee Lee, Shahin Shafiani, Beryl Crossley, et al.
Cancers
|
October 29, 2020
The Immune Phenotype of Isolated Lymphoid Structures in Non-Tumorous Colon Mucosa Encrypts the Information on Pathobiology of Metastatic Colorectal Cancer
Felicitas Mungenast, Anastasia Meshcheryakova, Andrea Beer, et al.
Journal for Immunotherapy of Cancer
|
November 29, 2016
Validation of biomarkers to predict response to immunotherapy in cancer: Volume II - clinical validation and regulatory considerations
Kevin K Dobbin, Alessandra Cesano, John Alvarez, et al.
Journal for Immunotherapy of Cancer
|
November 30, 2016
Validation of biomarkers to predict response to immunotherapy in cancer: Volume I - pre-analytical and analytical validation
Giuseppe V Masucci, Alessandra Cesano, Rachael Hawtin, et al.
Blood
|
April 12, 2015
IgH-V(D)J NGS-MRD measurement pre- and early post-allotransplant defines very low- and very high-risk ALL patients
Michael A Pulsipher, Chris Carlson, Bryan Langholz, et al.
Blood
|
December 30, 2017
Measurable residual disease detection by high-throughput sequencing improves risk stratification for pediatric B-ALL
Brent Wood, David Wu, Beryl Crossley, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 31) with videos related to
Sort By:
Page
of 4
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 8, 2017
Next-Generation Sequencing in Adult B Cell Acute Lymphoblastic Leukemia Patients
Olga Sala Torra, Megan Othus, David W Williamson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 28, 2014
Detection of minimal residual disease in B lymphoblastic leukemia by high-throughput sequencing of IGH
David Wu, Ryan O Emerson, Anna Sherwood, et al.
Science Translational Medicine
|
August 21, 2015
High-throughput pairing of T cell receptor α and β sequences
Bryan Howie, Anna M Sherwood, Ashley D Berkebile, et al.
American Journal of Hematology
|
May 4, 2026
Post CAR-T Measurable Residual Disease Monitoring in Mantle Cell Lymphoma Enables Early Detection of Disease Relapse
Snegha Ananth, Neha Agarwal, Bita Sahaf, et al.
Journal of Clinical Pathology
|
December 15, 2022
Characterisation of T cell receptor repertoires in coeliac disease
Lik Wee Lee, Shahin Shafiani, Beryl Crossley, et al.
Cancers
|
October 29, 2020
The Immune Phenotype of Isolated Lymphoid Structures in Non-Tumorous Colon Mucosa Encrypts the Information on Pathobiology of Metastatic Colorectal Cancer
Felicitas Mungenast, Anastasia Meshcheryakova, Andrea Beer, et al.
Journal for Immunotherapy of Cancer
|
November 29, 2016
Validation of biomarkers to predict response to immunotherapy in cancer: Volume II - clinical validation and regulatory considerations
Kevin K Dobbin, Alessandra Cesano, John Alvarez, et al.
Journal for Immunotherapy of Cancer
|
November 30, 2016
Validation of biomarkers to predict response to immunotherapy in cancer: Volume I - pre-analytical and analytical validation
Giuseppe V Masucci, Alessandra Cesano, Rachael Hawtin, et al.
Blood
|
April 12, 2015
IgH-V(D)J NGS-MRD measurement pre- and early post-allotransplant defines very low- and very high-risk ALL patients
Michael A Pulsipher, Chris Carlson, Bryan Langholz, et al.
Blood
|
December 30, 2017
Measurable residual disease detection by high-throughput sequencing improves risk stratification for pediatric B-ALL
Brent Wood, David Wu, Beryl Crossley, et al.
Page
of 4